Patents by Inventor Joelle Thonnard

Joelle Thonnard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Base205 polypeptides and polynucleotides therefor
    Publication number: 20040022803
    Abstract: The invention provides BASB205 polypeptides and polynucleotides encoding BASB205 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Application
    Filed: August 18, 2003
    Publication date: February 5, 2004
    Inventor: Joelle Thonnard
  • Moraxella catarrahalis polynucleotides and polypeptides
    Patent number: 6649171
    Abstract: The invention provides BASB021 polypeptides and polynucleotides encoding BASB021 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: November 18, 2003
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventor: Joelle Thonnard
  • Compounds from moraxella catarrhalis
    Patent number: 6627728
    Abstract: The invention provides BASB010 polypeptides and polynucleotides encoding BASB010 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
    Type: Grant
    Filed: July 16, 2001
    Date of Patent: September 30, 2003
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventor: Joelle Thonnard
  • Haemophilus influenza outer membrane protein and use thereof in vaccination
    Publication number: 20030096370
    Abstract: This invention relates to recombinant bacterial outer membrane proteins comprising one or more LB1(f) peptides from surface-exposed loop 3 of MOMP P5 of non-typeable H. influenzae. Polynucleotides encoding these recombinant proteins are also covered. The invention also relates to a method of isolating the recombinant proteins and a vaccine composition for use in the treatment of Haemophilus influenzae infection.
    Type: Application
    Filed: October 21, 2002
    Publication date: May 22, 2003
    Inventors: Francois-Xavier Jacques Berthet, Philippe Denoel, Jan Poolman, Joelle Thonnard